Eccrine sweat disorders
Chapter 12:Diseases of the skin and subcutaneous tissue
ICD-10 L74 is a used to indicate a diagnosis of eccrine sweat disorders.
Eccrine sweat disorders, classified under ICD-10 code L74, encompass a range of conditions affecting the eccrine sweat glands, which are responsible for thermoregulation and maintaining skin hydration. Clinically, these disorders may present as hyperhidrosis (excessive sweating), hypohidrosis (reduced sweating), or other dysfunctions of the eccrine glands. The eccrine glands are distributed throughout the body, particularly in areas such as the palms, soles, and forehead. Disease progression can vary; for instance, hyperhidrosis may lead to skin maceration, secondary infections, or social anxiety, while hypohidrosis can result in heat intolerance and increased risk of heat-related illnesses. Diagnostic considerations include a thorough patient history, physical examination, and, in some cases, sweat tests to measure sweat production. Understanding the underlying causes, which may be idiopathic or secondary to systemic conditions, is crucial for effective management and treatment planning.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L74 covers conditions such as primary hyperhidrosis, secondary hyperhidrosis, and hypohidrosis. Diagnostic criteria include the presence of excessive sweating in specific areas or reduced sweating due to underlying medical conditions.
L74 should be used when the primary issue is related to eccrine gland dysfunction, particularly when distinguishing between primary and secondary causes of sweating disorders. Related codes may apply if the sweating disorder is part of a broader systemic condition.
Documentation should include a detailed patient history, physical examination findings, and any diagnostic tests performed, such as sweat tests. Notes on the impact of the condition on the patient's quality of life and treatment responses are also essential.
